Archived here: https://archive.is/izHuk

From the article:

What if there was a cheap drug, so old its patent had expired, so safe that it’s on the WHO’s lists of Essential and Children’s Medicines, and used in mass drug administration rollouts? What if it can be taken at home with the first signs COVID symptoms, given to those in close contact, and significantly reduce COVID disease progression and cases, and far fewer few people would need hospitalisation?

.

The international vaccine rollout under Emergency Use Authorisation (EUA) would legally have to be halted. For an EUA to be legal, “there must be no adequate, approved and available alternative to the candidate product for diagnosing, preventing or treating the disease or condition.” The vaccines would only become legal once they passed level 4 trials and that certainly won’t happen in 2021.

.

This would present a major headache for the big public health agencies led by the WHO. The vaccine rollout, outside of trials, would become illegal. The vaccine manufactures, having spent hundreds of million dollars developing and testing vaccines during a pandemic, would not see the $100bn they were expecting in 2021. In a pandemic, and for the next one, we need big pharma to react quickly, and the best way to that, is to reward them financially. Allowing any existing drug, at this time, well into stage 3 trials, to challenge the legality of the EUA of vaccines, is not going to happen easily. On the 31st of March 2021, the WHO recommended against the use of Ivermectin for COVID treatment, citing safety and lack of large RCT proof.

.

The question of why the WHO would do this is difficult to answer, only if you ignore the importance of the legality of the EUA, and the time tested advice, of following the money. The WHO, a once noble organisation funded by the worlds countries, now receives less than 20% of its budget from member states. The Bill and Melinda Gates Foundation is the second biggest sponsor after the USA. The GAVI Alliance, a private/public organisation promoting vaccines, was founded by Gates, and now pushing for vaccine passports, are the 4th biggest sponsor to WHO. Tedros Adhanom Ghebreyesus, the WHO Director-General, served on the GAVI board for several years. The WHO, in 2021 changed the definition of “herd immunity”, to occurring only when the global population has been vaccinated.

.

In January this year, the several months long, Ivermectin research, meta-analysis of Randomised Control Trials (RCT), commissioned by WHO was released. The paper showed that Ivermectin reduces death by 74% and is 85% effective as prophylaxis. The trial leader, Dr Andrew Hill, was on Zoom meetings saying that governments should secure their source before demand outstrips supply and that it would be immoral, not to roll it out. The same month, two other independent, unsponsored meta-analysis confirmed a similar range of effectiveness at various stages of the disease. While effective at all stages of the disease, Ivermectin is most effective as a prophylaxis and about 80% in early treatment, depending on dose used.

.

Ivermectin has been used in humans for 35 years and over 4 billion doses have been administered. Merck, the original patent holder, donated 3.7 billion doses to developing countries.... While known primarily as an anti-parasitic, Ivermectin has powerful anti-viral and anti-inflammatory properties. Its safety is documented at doses twenty times the normal. Only 19 deaths are known and side-affects are generally mild and short. As a comparison, approximately 450 US citizens die from paracetamol every year.

.

Merck’s patent on Ivermectin expired in 1996 and they produce less than 5% of global supply. In 2020 they were asked to assist in Nigerian and Japanese trials but declined both. In 2021 Merck released a statement claiming that Ivermectin was not an effective treatment against Covid-19 and bizarrely claimed, “A concerning lack of safety data in the majority of studies” of the a drug they donated to be distributed in mass rollouts, by primary care workers, in mass campaigns, to millions in developing countries.